AAAAAA

   
Results: 1-10 |
Results: 10
In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography
Authors: Aboagye, EO Price, PM Jones, T
Citation: Eo. Aboagye et al., In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography, DRUG DISC T, 6(6), 2001, pp. 293-302
Pharmacokinetic evaluation of N-[2(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography
Authors: Saleem, A Harte, RJ Matthews, JC Osman, S Brady, F Luthra, SK Brown, GD Bleehen, N Conners, T Jones, T Price, PM Aboagye, EO
Citation: A. Saleem et al., Pharmacokinetic evaluation of N-[2(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography, J CL ONCOL, 19(5), 2001, pp. 1421-1429
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues
Authors: Osman, S Rowlinson-Busza, G Luthra, SK Aboagye, EO Brown, GD Brady, F Myers, R Gamage, SA Denny, WA Baguley, BC Price, PM
Citation: S. Osman et al., Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues, CANCER RES, 61(7), 2001, pp. 2935-2944
Extraction of 5-Fluorouracil by tumor and liver: A noninvasive positron emission tomography study of patients with gastrointestinal cancer
Authors: Aboagye, EO Saleem, A Cunningham, VJ Osman, S Price, PM
Citation: Eo. Aboagye et al., Extraction of 5-Fluorouracil by tumor and liver: A noninvasive positron emission tomography study of patients with gastrointestinal cancer, CANCER RES, 61(13), 2001, pp. 4937-4941
In vivo monitoring of drugs using radiotracer techniques
Authors: Saleem, A Aboagye, EO Price, PM
Citation: A. Saleem et al., In vivo monitoring of drugs using radiotracer techniques, ADV DRUG DE, 41(1), 2000, pp. 21-39
Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action
Authors: Saleem, A Yap, J Osman, S Brady, F Suttle, B Lucas, SV Jones, T Price, PM Aboagye, EO
Citation: A. Saleem et al., Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action, LANCET, 355(9221), 2000, pp. 2125-2131
Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A P-31 nuclear magnetic resonance study in vivo and in vitro
Authors: Bhujwalla, ZM Aboagye, EO Gillies, RJ Chacko, VP Mendola, CE Backer, JM
Citation: Zm. Bhujwalla et al., Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A P-31 nuclear magnetic resonance study in vivo and in vitro, MAGN RES M, 41(5), 1999, pp. 897-903
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells
Authors: Aboagye, EO Bhujwalla, ZM
Citation: Eo. Aboagye et Zm. Bhujwalla, Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells, CANCER RES, 59(1), 1999, pp. 80-84
Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography (vol 13, pg 703, 1998)
Authors: Aboagye, EO Kelson, AB Tracy, M Workman, P
Citation: Eo. Aboagye et al., Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography (vol 13, pg 703, 1998), ANTI-CAN DR, 13(8), 1998, pp. 1009-1010
Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography
Authors: Aboagye, EO Kelson, AB Tracy, M Workman, P
Citation: Eo. Aboagye et al., Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography, ANTI-CAN DR, 13(6), 1998, pp. 703-730
Risultati: 1-10 |